Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 08:03:58 AM Tue, 24 Jul 2018   Contact Information Dimitrios P. Kontoyiannis Associated Profiles  The Texas 4000 Distinguished Endowed Professor For Cancer Research, Deputy Head Research, Internal Medicine, UT MD Anderson Cancer Center     dkontoyi@mdanderson.org     713-792-0826    Web Link    Lab Webpage    Aspergillosis, Infection, Aspergillus, Caspofungin, Mycoses, Mucormycosis, Fungi, Aspergillus Fumigatus    Associated Profiles Professional Preparation Research and Expertise Affiliations Appointments  Professional Preparation  Degree Major Institution Year  DSc Medical Sciences University of Crete 1998  MSc Medical Sciences Harvard University Medical School 1997  MD Medical Sciences National and Kapodistrian University of Athens 1987  Research and Expertise Research Interests   Invasive fungal infections (IFIs) are leading causes of death in patients with leukemia and hematopoietic cell transplant recipients in our institution. Dimitrios Kontoyiannis, M.D., Sc.D., and his lab team are studying the pathogenesis of IFIs and the development of novel therapeutic strategies against these devastating infections. Antifungal resistance, novel diagnostics and delivery systems and fungal pharmacology are also areas of interest. Specifically, for the last 18 years, the Kontoyiannis Laboratory has made significant contributions towards establishing the conceptual framework for correlating antifungal resistance with outcome of antifungal therapy, the activity of novel antifungal compounds, and combination therapy. The team has also developed novel experimental Drosophila models to study antifungal therapy and fungal pathogenesis, in vivo pharmacodynamics of antifungals and novel diagnostics. This work has led to several awards and recognitions nationally and internationally. In terms of his work in clinical mycology, Kontoyiannis has authored numerous studies focusing on the epidemiology, natural history, prognosis and management of virtually every common mycosis that afflicts immunocompromised patients with cancer. He has been extensively involved in the design and implementation of several clinical trials of novel antifungal agents for both the prophylaxis and treatment, and is a member of the writing committee for the IDSA Aspergillus treatment guidelines.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Research Consortia GCC Consortium for Antimicrobial Resistance (GCC AMR)  Training Grants Training Program in Antimicrobial Resistance (TPAMR) Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)  Appointments Title Department / School Institution Deputy Head Research Internal Medicine MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.